| Literature DB >> 19034557 |
Susan L M Coort1, Martijn P van Iersel, Marjan van Erk, Teake Kooistra, Robert Kleemann, Chris T A Evelo.
Abstract
Insulin resistance is a characteristic of type-2 diabetes and its development is associated with an increased fat consumption. Muscle is one of the tissues that becomes insulin resistant after high fat (HF) feeding. The aim of the present study is to identify processes involved in the development of HF-induced insulin resistance in muscle of ApOE3*Leiden mice by using microarrays. These mice are known to become insulin resistant on a HF diet. Differential gene expression was measured in muscle using the Affymetrix mouse plus 2.0 array. To get more insight in the processes, affected pathway analysis was performed with a new tool, PathVisio. PathVisio is a pathway editor customized with plug-ins (1) to visualize microarray data on pathways and (2) to perform statistical analysis to select pathways of interest. The present study demonstrated that with pathway analysis, using PathVisio, a large variety of processes can be investigated. The significantly regulated genes in muscle of ApOE3*Leiden mice after 12 weeks of HF feeding were involved in several biological pathways including fatty acid beta oxidation, fatty acid biosynthesis, insulin signaling, oxidative stress and inflammation.Entities:
Year: 2008 PMID: 19034557 PMCID: PMC2593012 DOI: 10.1007/s12263-008-0100-7
Source DB: PubMed Journal: Genes Nutr ISSN: 1555-8932 Impact factor: 5.523
The 25 highest ranked pathways based on z score
| Pathway | Positive ( | Measured ( | Total | % |
|
|---|---|---|---|---|---|
| Fatty acid biosynthesis | 15 | 19 | 22 | 78.95 | 5.91 |
| Fatty acid beta oxidation 1 | 14 | 23 | 27 | 60.87 | 4.42 |
| Muscle, fat and connective tissue specific genes | 16 | 28 | 55 | 57.14 | 4.41 |
| Pentose phosphate pathway | 6 | 7 | 8 | 85.71 | 4.01 |
| Beta oxidation meta MAPP | 15 | 28 | 32 | 53.57 | 3.95 |
| Mitochondrial LC-fatty acid beta-oxidation | 9 | 15 | 16 | 60.00 | 3.49 |
| Genes specific to internal organs | 30 | 79 | 202 | 37.97 | 3.32 |
| Genes specific to blood and lymph tissue | 7 | 11 | 17 | 63.64 | 3.28 |
| Glutathione metabolism | 9 | 16 | 38 | 56.25 | 3.24 |
| Irinotecan pathway | 5 | 7 | 13 | 71.43 | 3.11 |
| Fatty acid beta oxidation 2 | 4 | 6 | 6 | 66.67 | 2.6 |
| Genes specific to blood and lymph tissue | 9 | 21 | 40 | 42.86 | 2.24 |
| Myometrial relaxation and contraction pathways | 33 | 105 | 161 | 31.43 | 2.22 |
| Alanine and aspartate metabolism | 4 | 7 | 40 | 57.14 | 2.2 |
| Inflammatory response pathway | 10 | 25 | 41 | 40.00 | 2.11 |
| Cholesterol biosynthesis | 5 | 10 | 15 | 50.00 | 2.09 |
| Circadian exercise | 13 | 35 | 49 | 37.14 | 2.09 |
| Triacylglyceride synthesis | 8 | 19 | 25 | 42.11 | 2.06 |
| Mouse insulin signaling | 36 | 121 | 160 | 29.75 | 1.94 |
| Oxidative stress | 9 | 23 | 29 | 39.13 | 1.92 |
| G Protein signaling pathways | 20 | 61 | 87 | 32.79 | 1.89 |
| Tryptophan metabolism | 11 | 30 | 87 | 36.67 | 1.87 |
| Fatty acid beta oxidation 3 | 4 | 8 | 8 | 50.00 | 1.87 |
| Striated muscle contraction | 8 | 21 | 45 | 38.10 | 1.72 |
| Nuclear receptors in lipid metabolism and toxicity | 7 | 18 | 34 | 38.89 | 1.67 |
Genes were considered to be regulated (positive for the set criterion) if the fold change (FC) is smaller than −1.2 or higher than 1.2 and the P value ≤0.05. Positive (r) are the number of genes in the pathway that meet the above-mentioned criterion. Measured (n) are the number of genes in the pathway that are present on the microarray. Total is the total amount of genes in a specific pathway. Percentage (%) is the percentage of the measured genes meeting the set criterion
Fig. 1Gene expression data mapped on the Mus musculus fatty acid beta oxidation 1 pathway. Fold changes are represented as a gradient and visualized per genebox on the left. Yellow boxes indicate a significance of P ≤ 0.05 and are visualized per genebox on the right. Light gray boxes indicate not significant and are also visualized on the right. The dark gray boxes represent the genes that could not be measured
Fig. 2Gene expression data mapped on the Mus musculus fatty acid synthesis pathway. Fold changes are represented as a gradient and visualized per genebox on the left. Yellow boxes indicate a significance of P ≤ 0.05 and are visualized per genebox on the right. Light gray boxes indicate not significant and are also visualized on the right. The dark gray boxes represent the genes that could not be measured
Fig. 3Gene expression data mapped on the mouse insulin signaling pathway. Fold changes are represented as a gradient and visualized per genebox on the left. Yellow boxes indicate a significance of P ≤ 0.05 and are visualized per genebox on the right. Light gray boxes indicate not significant and are also visualized on the right. The dark gray boxes represent the genes that could not be measured